Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2019
Price : $35 *
At a glance
- Drugs Enoxaparin sodium (Primary) ; Rosuvastatin (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Pharmacodynamics
- Acronyms O-STAT Study
- 15 Oct 2018 Status changed from not yet recruiting to recruiting.
- 23 Jul 2018 Planned initiation date changed from 1 Jul 2018 to 25 Jul 2018.
- 26 Jun 2018 Planned initiation date changed from 31 May 2018 to 1 Jul 2018.